Duravest Launches New Corporate Web Site Focused on Convergent Medical Technologies
21 May 2006
Duravest, Inc. (OTC BB: DUVTE),(XETRA: DUV), a unique company that strategically acquiresand accelerates the development of next generationconvergent medical technology firms, today launched acompletely redesigned corporate web site dedicated to theadvancement of convergent medical technologies within theinvestment, clinical and academic communities. The sitewill also feature recent developments and thought-leadershipin advancing safety considerations in the development ofmedical technologies.
The company's new web site, created by Epsilonium Systems,is designed specifically to enhance the knowledge ofconvergent medical technologies and to be a home for news,information, and important policymaking decisions related tothis high growth industry. The new Duravest website willalso serve as an important information resource for itsinvestors, subsidiaries, affiliates and other stakeholders.
Duravest's innovative web site can be found atwww.duravestinc.com. New content will be added daily.
"We are excited about the role Duravest can take in raisingthe awareness and accelerating the development of bothdevelopment-stage and established companies operating inthis area," Dr. Ogan Gurel, CEO of Duravest and a notedthought leader in the industry, said Thursday. "TheDuravest corporate web site should be a hub for industryprofessionals, investors, policymakers, scientists,clinicians and the media in the rapidly expanding field ofconvergent/combination medical technologies."
ARCH Conference Presentation Webcast Available
Dr. Gurel presented at the May 18 ARCH Investment Conferenceat the Hotel Plaza Athenee in New York City. The purpose ofthe conference was to introduce high growth companies, likeDuravest, to the investment community.
Please visithttp://www.investorcalendar.com/CEPage.asp?ID=104912 for thearchived web cast of Dr. Gurel's May 18 investorpresentation.
The presentation link can also be found atwww.duravestinc.com.
About Epsilonium Systems
Epsilonium Systems is an international creative design ande-business applications company developing innovative andsophisticated web solutions for their clients. Headquarteredin Phoenix with a location in Kanpur, India, Epsiloniumdelivers a wide range of design, development, and completelife-cycle management solutions. For more information,please visit www.epsilonium.com.
About Duravest, Inc.
Duravest, Inc. is a publicly traded holding company thatinitiates and develops strategic investments innext-generation convergent medical technologies. Duravestcurrently has two subsidiaries: Estracure, Inc. and PST,GmbH (formerly known as Bio-Magnetic Therapy Systems, GmbH).The Duravest strategy encompasses three themes: (1) rapidcommercialization ofnext-generation medical technologies by providing itsportfolio of subsidiaries with financial, operational andscientific support, (2) prioritization of safety and (3)development of convergent medical technologies that span thetraditional categories of biotechnology, pharmaceuticals,healthcare IT and medical devices.
Safe Harbor Forward-Looking Statements
This release contains forward-looking statements within themeaning of Section 27A of the Securities Act of 1933 andSection 21B of the Securities Exchange Act of 1934. Anystatements that express or involve discussions with respectto predictions, expectations, beliefs, plans, projections,objectives, goals or assumptions of future events are notstatements of historical fact and may be consideredforward-looking statements. They involve a number of risksand uncertainties, which could cause actual results orevents to differ materially from those presentlyanticipated.
SOURCE: Duravest, Inc.
Source: marketwire
All trademarks and copyrighted information contained herein are the property of their respective owners.
Related Articles
|
